Brian Tyler, Leading a Trusted Brand McKesson
Purnima Narang || The CEO Magazine
With an estimated net worth of 6.58 Million dollars as at 30 May 2019, Brain Scott Tyler is the President, Chief Executive Officer and Director of Mckesson. He owns over 1,488 units of McKesson stock worth over $1,684,569. Tyler has been leading the 186-year-old trusted brand that started delivering medicine by horse and buggy in 1833 and currently providing healthcare solutions across the globe with McKesson Canada, Mckesson United Kingdom, McKesson Australia and New Zealand.
The American company distributes pharmaceuticals and provides health information, medical supplies, and care management tools to its customers. Under the leadership of a visionary leader Brain Tyler, McKesson has recorded revenues of $208.4 billion in 2018.
Based in Irving, Texas, the brand’s commitment towards delivering value to the customers and stakeholders has been very straightforward as it ensures fair and ethical dealings with our suppliers, customers, government partners, supporting the communities in which it works and investing in its employees.
McKesson has various divisions within the organization to direct focused attention on each of its products and services. McKesson Provider Technologies, McKesson Medical Supplies and equipment and Health Mart Pharmacy Franchise are the divisions of the brand.
Brian S. Tyler is the chief executive officer of McKesson Corporation with his more than two decades of experience with McKesson as he served in a wide variety of leadership roles throughout the company leading various major businesses within the company as well as McKesson’s corporate strategy and business development unit. Recently Tyler has served as Chairman of the Management Board of McKesson Europe, where he drove growth to $27.3 billion by focusing on operational excellence, collaboration and innovation.
Tyler completed his B.A. in Economics with high honours from the University of California, Santa Cruz. He earned his PhD and master’s degree from the University of Chicago, Department of Economics where he studied under a grant from the National Science Foundation. His specializations include Industrial Organization, Labour Economics, and Public Finance/Project Evaluation. Tyler spent three years at Integral, Inc. as a senior associate, Health Care Consulting in Cambridge before joining the brand McKesson.
Before leading McKesson Europe, he had overall leadership responsibility for McKesson’s pharmaceutical distribution and related businesses in North America. Tyler is a member of the board of directors of the International Federation of Pharmaceutical Wholesalers (IFPW), a member of the IFPW Foundation board of directors, and a member of the American Cancer Society’s CEOs against Cancer group in the North Texas chapter.
The company deals in ensuring healthcare for each patient with each of the products every day by touching virtually every aspect of healthcare. It is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.
McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments and others to deliver the right medicines, medical products and healthcare services to the patients who need them, when they need them — safely and cost-effectively. The team of 78,000 employees led by Brain S Tyler works together every day to make better care possible for patients around the globe following ICARE values.
Heading nearly every major business within the company as well as McKesson’s corporate strategy and business development unit, Brian has been integral part of the. Most recently, Tyler served as COO and president of McKesson. He also is a part of the company’s Board of Directors and is taking the business to new heights of excellence.